Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

May 2017


Roche develop patient facing material to support self-monitoring of INR – “I know my value – Be an active part of your anticoagulation therapy with INR self-monitoring” – citing 2012 systematic review.

August 2017


ESC/EACTS Guidelines for the management of valvular heart disease – Cite 2012 Lancet review on self-monitoring.

September 2017


Inhealthcare launches an INR self-testing service for NHS patients in Manchester – citing 2012 Cochrane systematic review. “Inhealthcare is supplying the pioneering technology for the service, which is being delivered by staff from The Pennine Acute Hospitals NHS Trust, which runs North Manchester General Hospital.

It is available for up to 200 patients with Atrial Fibrillation in North Manchester. Their respective clinics will still be their first point of contact if they have any problems or concerns.”

November 2017


NICE Clinical Knowledge summaries – What is the starting dose when warfarin therapy is initiated? – Recommendations from 2011 BSH guidance which cites 2006 and 2010 systematic review.


NICE Clinical Knowledge Summaries (Anticoagulation) – Are self-testing and self-management as safe and effective as routine management?

Recommendations include:

  • For selected and successfully trained people, self-testing or self-management are as effective and safe as usual care for long-term oral anticoagulation therapy and can improve the quality of oral anticoagulation therapy in this group of people.
  • However, in the UK, self-testing is unlikely to be more cost-effective than usual care, because of the increased frequency of testing and subsequent cost of test strips.

The basis for the recommendation – heavily reference 2016 Cochrane systematic review on self-monitoring.